Biobase Sweden AB closes the last of three planned capitalization rounds for 2022. 8 million SEK at an evaluation of 40 million SEK pre-money
We are happy to announce that Biobase Sweden AB closes the third and final round of capitalization for 2022. 8 million SEK at an evaluation